ICH M13 draft Guideline reaches Step 2 of the ICH process
The ICH M13A draft Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage Forms reached Step 2 of the ICH process on 20 December 2022.
The ICH M13A draft Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage Forms reached Step 2 of the ICH process on 20 December 2022.
Added in December 2022 22 December NEW - Report from the meeting held on 13-14 December 19 December NEW - 8-10 November CMDh Minutes 16 December UPDATE - Decisions on additional year of market protection/data exclusivity for new therapeutic indication agreed by the CMDh 15 December NEW - 13-14 December CMDh Agenda 5 December 2022 UPDATE [...]
The Assembly of the International Council for Harmonisation (ICH) met in-person on the 15 - 16 November 2022, in Incheon, Republic of Korea in parallel of meetings of ten Working Groups, and preceded by meetings of the ICH Management Committee and the MedDRA Management Committee.
Euvax B (Vaccinum hepatitidis B (ADNr)) End of procedure: 12/10/2022 Date of publication: 16/11/2022
Decapeptyl / Diphereline /Arvekap (triptorelin) PT/W/0003/pdWS/001 End of procedure: 04/07/2013 Date of publication: 16/11/2022 PT/W/0003/pdWS/002 End of procedure: 30/06/2023 Date of publication: 03/04/2024
EMA is pleased to announce the web-based Human Variations electronic application form (eAF) for Centrally Authorised Products (CAPs) is now available on the new Product Lifecycle Management (PLM) Portal. This is a big, first milestone in the ongoing journey to improve the eAFs and related processes. EMA has been collaborating with the UNICOM consortium to [...]
An updated version of the PLM Portal (eAF) guide to registration is now available on PLM Portal eAF (DADI). The guide aims to support the users of the eAF Portal in completing the registration steps before accessing the PLM Portal. Most of these steps are independent from the PLM Portal eAF and correspond to those [...]
The ICH E19 Guideline on A Selective Approach to Safety Data Collection in Specific Late-stage Pre-approval or Post-approval Clinical Trials reached Step 4 of the ICH Process in September 2022.
The ICH M11 draft Guideline on Clinical electronic Structured Harmonised Protocol (CeSHarP), Technical Specification and Template reached Step 2 of the ICH process on 27 September 2022.
Iohexol Date of publication: 25/10/2022